相似文献
1
Phencyclidine/schizophrenia: one view toward the past, the other to the future.苯环利定/精神分裂症：一个是对过去的看法，另一个是对未来的看法。
Schizophr Bull. 2012 Sep;38(5):914-9. doi: 10.1093/schbul/sbs011. Epub 2012 Mar 5.
2
Twenty-five years of glutamate in schizophrenia: are we there yet?精神分裂症中谷氨酸 25 年的研究历程：我们成功了吗？
Schizophr Bull. 2012 Sep;38(5):911-3. doi: 10.1093/schbul/sbs100.
3
DARK Classics in Chemical Neuroscience: Phencyclidine (PCP).《化学神经科学经典系列：苯环己哌啶（PCP）》
ACS Chem Neurosci. 2018 Oct 17;9(10):2459-2474. doi: 10.1021/acschemneuro.8b00266. Epub 2018 Jul 17.
4
NMDA receptor and schizophrenia: a brief history.NMDA 受体与精神分裂症：简要的历史。
Schizophr Bull. 2012 Sep;38(5):920-6. doi: 10.1093/schbul/sbs076.
5
History of anaesthesia: The ketamine story - past, present and future.麻醉史：氯胺酮的故事——过去、现在与未来。
Eur J Anaesthesiol. 2017 Sep;34(9):571-575. doi: 10.1097/EJA.0000000000000638.
6
[Phencyclidine (PCP): a psychotomimetic drug. Case report and review of literature].[苯环利定（PCP）：一种拟精神病药物。病例报告及文献综述]
Schweiz Med Wochenschr. 1983 Oct 1;113(39):1396-402.
7
A review of NMDA receptors and the phencyclidine model of schizophrenia.N-甲基-D-天冬氨酸受体与精神分裂症苯环利定模型综述。
Pharmacotherapy. 1996 Jan-Feb;16(1):82-93.
8
Taming the ketamine tiger. 1965.驯服氯胺酮这只老虎。1965 年。
Anesthesiology. 2010 Sep;113(3):678-84. doi: 10.1097/ALN.0b013e3181ed09a2.
9
Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study.精神分裂症特发性精神病与药物所致可卡因和苯环利定精神病的现象学比较：一项回顾性研究。
Clin Neuropharmacol. 1994 Aug;17(4):359-69. doi: 10.1097/00002826-199408000-00008.
10
Abuse liability of novel 'legal high' designer stimulants: evidence from animal models.新型“合法兴奋剂”类设计型兴奋剂的滥用倾向：来自动物模型的证据。
Behav Pharmacol. 2013 Sep;24(5-6):341-55. doi: 10.1097/FBP.0b013e3283641ec8.
引用本文的文献
1
Identifying dysfunctional cell types and circuits in animal models for psychiatric disorders with calcium imaging.利用钙成像技术在精神疾病动物模型中识别功能失调的细胞类型和回路。
Neuropsychopharmacology. 2024 Nov;50(1):274-284. doi: 10.1038/s41386-024-01942-y. Epub 2024 Aug 9.
2
Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?“神秘体验”对于氯胺酮和经典致幻剂的抗抑郁作用是否至关重要？
Eur Arch Psychiatry Clin Neurosci. 2024 Feb 27. doi: 10.1007/s00406-024-01770-7.
3
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.N-甲基-D-天冬氨酸受体调节剂在精神病学中的治疗潜力。
Neuropsychopharmacology. 2024 Jan;49(1):51-66. doi: 10.1038/s41386-023-01614-3. Epub 2023 Jun 27.
4
Arketamine for cognitive impairment in psychiatric disorders.氯胺酮治疗精神障碍的认知障碍。
Eur Arch Psychiatry Clin Neurosci. 2023 Oct;273(7):1513-1525. doi: 10.1007/s00406-023-01570-5. Epub 2023 Feb 14.
5
NX210c Peptide Promotes Glutamatergic Receptor-Mediated Synaptic Transmission and Signaling in the Mouse Central Nervous System.NX210c 肽促进小鼠中枢神经系统中谷氨酸能受体介导的突触传递和信号转导。
Int J Mol Sci. 2022 Aug 9;23(16):8867. doi: 10.3390/ijms23168867.
6
What Can We Learn from Animal Models to Study Schizophrenia?我们能从动物模型中学到什么来研究精神分裂症？
Adv Exp Med Biol. 2022;1400:15-33. doi: 10.1007/978-3-030-97182-3_2.
7
Modified climbing fiber/Purkinje cell synaptic connectivity in the cerebellum of the neonatal phencyclidine model of schizophrenia.精神分裂症幼鼠匹鲁卡品模型小脑内改良的 climbing fiber/Purkinje 细胞突触连接。
Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2122544119. doi: 10.1073/pnas.2122544119. Epub 2022 May 19.
8
Repeated intermittent administration of (R)-ketamine during juvenile and adolescent stages prevents schizophrenia-relevant phenotypes in adult offspring after maternal immune activation: a role of TrkB signaling.在幼年和青少年阶段反复间歇性给予（R）-氯胺酮可预防母体免疫激活后成年后代的精神分裂症相关表型：TrkB 信号的作用。
Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):693-701. doi: 10.1007/s00406-021-01365-6. Epub 2022 Jan 3.
9
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor.亚胺培南抗抑郁作用的分子机制：超越 NMDA 受体。
Mol Psychiatry. 2022 Jan;27(1):559-573. doi: 10.1038/s41380-021-01121-1. Epub 2021 May 7.
10
The Ketamine Antidepressant Story: New Insights.《氯胺酮抗抑郁作用的故事：新见解》
Molecules. 2020 Dec 7;25(23):5777. doi: 10.3390/molecules25235777.
本文引用的文献
1
GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression.在精神分裂症患者的视觉皮层中，GABA 浓度降低，并且与方向特异性周围抑制有关。
J Neurosci. 2010 Mar 10;30(10):3777-81. doi: 10.1523/JNEUROSCI.6158-09.2010.
2
GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.γ-氨基丁酸A型（GABA(A)）受体及其相关蛋白：对精神分裂症及相关疾病病因和治疗的影响
Neuropharmacology. 2009 Oct-Nov;57(5-6):481-95. doi: 10.1016/j.neuropharm.2009.07.027. Epub 2009 Jul 23.
3
Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia.超越多巴胺假说，迈向精神分裂症的N-甲基-D-天冬氨酸（NMDA）谷氨酸受体功能减退假说。
CNS Spectr. 2007 Apr;12(4):265-8. doi: 10.1017/s1092852900021015.
4
Schizophrenia genes - famine to feast.精神分裂症基因——从饥荒到盛宴。
Biol Psychiatry. 2006 Jul 15;60(2):81-3. doi: 10.1016/j.biopsych.2006.06.002.
5
Cortical inhibitory neurons and schizophrenia.皮质抑制性神经元与精神分裂症
Nat Rev Neurosci. 2005 Apr;6(4):312-24. doi: 10.1038/nrn1648.
6
Model psychoses and schizophrenia.典型精神病与精神分裂症
Am J Psychiatry. 1962 Jul;119:61-7. doi: 10.1176/ajp.119.1.61.
7
Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception.塞尼耳与其他药物的比较：用塞尼耳、麦角酸二乙酰胺（LSD - 25）和异戊巴比妥钠模拟精神分裂症患者的行为表现；I. 注意力、运动功能和本体感觉。
AMA Arch Gen Psychiatry. 1959 Dec;1:651-6. doi: 10.1001/archpsyc.1959.03590060113013.
8
Electroencephalographic findings associated with sernyl infusion.与塞尼耳输注相关的脑电图检查结果。
Electroencephalogr Clin Neurophysiol. 1959 Nov;11:796-8. doi: 10.1016/0013-4694(59)90122-1.
9
THE SYNTHESIS OF PHENCYCLIDINE AND OTHER 1-ARYLCYCLOHEXYLAMINES.
J Med Chem. 1965 Mar;8:230-5. doi: 10.1021/jm00326a019.
10
NEUROBIOLOGY OF PHENCYCLIDINE (SERNYL), A DRUG WITH AN UNUSUAL SPECTRUM OF PHARMACOLOGICAL ACTIVITY.苯环利定（塞尼耳）的神经生物学，一种具有异常药理活性谱的药物。
Int Rev Neurobiol. 1964;6:303-47. doi: 10.1016/s0074-7742(08)60772-2.
Zotero 插件